Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
(... Continued)<br />
Study or subgroup DHA-P AS+MQ Risk Ratio Weight Risk Ratio<br />
n/N n/N M-H,Random,95% CI M-H,Random,95% CI<br />
Subtotal (95% CI) 561 563 100.0 % 9.68 [ 1.23, 75.98 ]<br />
Total events: 9 (DHA-P), 0 (AS+MQ)<br />
Heterogeneity: Tau 2 = 0.0; Chi 2 = 0.08, df = 1 (P = 0.78); I 2 =0.0%<br />
Test <strong>for</strong> overall effect: Z = 2.16 (P = 0.031)<br />
0.001 0.01 0.1 1 10 100 1000<br />
Favours DHA-P Favours AS+MQ<br />
Analysis 1.10. Comparison 1 Dihydroartemisinin-piperaquine vs Artesunate plus mefloquine, Outcome 10<br />
Serious adverse events (including deaths).<br />
Review: <strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria<br />
Comparison: 1 Dihydroartemisinin-piperaquine vs Artesunate plus mefloquine<br />
Outcome: 10 Serious adverse events (including deaths)<br />
Study or subgroup DHA-P AS+MQ Risk Ratio Risk Ratio<br />
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI<br />
Ashley 2003a THA 0/67 0/67 0.0 [ 0.0, 0.0 ]<br />
Janssens 2003 KHM 0/228 0/236 0.0 [ 0.0, 0.0 ]<br />
Ashley 2003b THA 1/179 0/176 2.95 [ 0.12, 71.93 ]<br />
Mayxay 2004 LAO 0/110 1/110 0.33 [ 0.01, 8.09 ]<br />
Ashley 2004 THA 11/333 4/166 1.37 [ 0.44, 4.24 ]<br />
Grande 2005 PER 0/262 3/260 0.14 [ 0.01, 2.73 ]<br />
Tangpukdee 2005 THA 0/120 0/60 0.0 [ 0.0, 0.0 ]<br />
Total (95% CI) 1299 1075 0.90 [ 0.38, 2.15 ]<br />
Total events: 12 (DHA-P), 8 (AS+MQ)<br />
Heterogeneity: Chi 2 = 2.93, df = 3 (P = 0.40); I 2 =0.0%<br />
Test <strong>for</strong> overall effect: Z = 0.23 (P = 0.82)<br />
<strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria (Review)<br />
Copyright © 2009 <strong>The</strong> <strong>Cochrane</strong> Collaboration. Published by John Wiley & Sons, Ltd.<br />
0.001 0.01 0.1 1 10 100 1000<br />
Favours DHA-P Favours AS+MQ<br />
131